Cargando…
Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers
BACKGROUND: The proposed involvement of CD151 in breast cancer (BCa) progression is based on findings from studies in invasive ductal carcinoma (IDC). The IDC and invasive lobular carcinoma (ILC) represent distinct disease entities. Here we evaluated clinical significance of CD151 alone and in assoc...
Autores principales: | Romanska, Hanna M, Potemski, Piotr, Krakowska, Magdalena, Mieszkowska, Magdalena, Chaudhri, Shalini, Kordek, Radzisław, Kubiak, Robert, Speirs, Valerie, Hanby, Andrew M, Sadej, Rafał, Berditchevski, Fedor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815791/ https://www.ncbi.nlm.nih.gov/pubmed/26418423 http://dx.doi.org/10.1038/bjc.2015.344 |
Ejemplares similares
-
The Tetraspanin CD151 in Papillomavirus Infection
por: Scheffer, Konstanze D., et al.
Publicado: (2014) -
FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells
por: Turczyk, Lukasz, et al.
Publicado: (2017) -
CD151 in Respiratory Diseases
por: Wong, Amanda H., et al.
Publicado: (2020) -
MicroRNAs in regulation of triple-negative breast cancer progression
por: Piasecka, Dominika, et al.
Publicado: (2018) -
Profiling of Invasive Breast Carcinoma Circulating Tumour Cells—Are We Ready for the ‘Liquid’ Revolution?
por: Braun, Marcin, et al.
Publicado: (2019)